CIBC Private Wealth Group LLC Sells 7,338 Shares of Lam Research Corporation $LRCX

CIBC Private Wealth Group LLC cut its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 15.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 39,048 shares of the semiconductor company’s stock after selling 7,338 shares during the period. CIBC Private Wealth Group LLC’s holdings in Lam Research were worth $5,229,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Stance Capital LLC bought a new position in shares of Lam Research in the third quarter worth about $26,000. Triumph Capital Management purchased a new position in shares of Lam Research in the third quarter valued at about $27,000. Howard Hughes Medical Institute purchased a new position in Lam Research in the 2nd quarter worth approximately $27,000. Sound Income Strategies LLC bought a new position in shares of Lam Research during the third quarter worth $41,000. Finally, Measured Wealth Private Client Group LLC purchased a new position in shares of Lam Research during the third quarter valued at about $40,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Price Performance

Shares of LRCX opened at $228.36 on Friday. The business’s 50-day moving average is $226.92 and its two-hundred day moving average is $177.01. The company has a market capitalization of $285.17 billion, a P/E ratio of 46.80, a P/E/G ratio of 2.52 and a beta of 1.77. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $256.68. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.61 and a current ratio of 2.26.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. The company’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be given a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio is currently 21.31%.

Insiders Place Their Bets

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the sale, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total transaction of $333,990.00. Following the transaction, the insider directly owned 53,205 shares of the company’s stock, valued at approximately $11,846,625.30. This trade represents a 2.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 130,886 shares of company stock worth $29,658,802. Corporate insiders own 0.31% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on LRCX shares. The Goldman Sachs Group set a $262.00 target price on shares of Lam Research and gave the company a “buy” rating in a report on Thursday, January 29th. Weiss Ratings reiterated a “buy (b)” rating on shares of Lam Research in a report on Monday, December 29th. Jefferies Financial Group reiterated a “buy” rating and issued a $200.00 price target (up from $175.00) on shares of Lam Research in a report on Monday, December 15th. Sanford C. Bernstein raised their price target on Lam Research from $275.00 to $285.00 and gave the stock an “outperform” rating in a research note on Monday, February 9th. Finally, JPMorgan Chase & Co. boosted their price objective on Lam Research from $165.00 to $300.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and a consensus price target of $245.35.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.